Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Urinary Tract Infections

Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide, imposing significant clinical, economic, and humanistic burdens. This chapter explores the evidence-based role of pharmacists in the prevention, early detection, and optimal management of UTIs. Clinically, pharmacists contribute by ensuring rational antibiotic use, improving adherence, monitoring outcomes, and educating patients to reduce recurrence and complications. Economically, pharmacist-led interventions reduce healthcare expenditures through cost-effective therapy, decreased hospitalizations, and improved antibiotic stewardship. Humanistically, pharmacists enhance patients’ quality of life by addressing symptoms, providing personalized counseling, promoting health literacy, and supporting treatment satisfaction. The chapter also highlights facilitators and barriers influencing pharmacists’ effectiveness in UTI management, such as scope of practice, collaboration, and access to diagnostics. Overall, integrating 204 pharmacists into UTI care pathways improves treatment outcomes and supports a sustainable, patient-centered healthcare model.